Investor Relations Home

There are no items to display.

Stock Quote

MASI (Common Stock)
Exchange
Price
Change (%)
Volume
Data as of Copyright Nasdaq. Minimum 15 minutes delayed.

Online Investor Kit

	Masimo Reports First Quarter 2017 Financial Results
	2016 Annual Report
	2016 Form 10K
	2017 Proxy Statement
	2017 Proxy Statement Supplement No.1
	2017 Proxy Statement Supplement No. 2

Corporate Profile

We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... More >>

Upcoming Events

More >>

There are currently no events to display.

Recent News

RSS Feeds | More >>

11/09/07

Summary Toggle Masimo Corporation Adopts Stockholder Rights Plan IRVINE, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Masimo (Nasdaq: MASI) the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, announced today that the Pricing Committee of its Board of Directors has formally adopted a stockholder rights plan.
11/08/07

Summary Toggle National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning NAEMSE Letter to Members Warns of Critical and Fatal Implications of Missing the Diagnosis of Carbon Monoxide Poisoning IRVINE, Calif., Nov.
11/01/07

Summary Toggle Community Health Network of Indianapolis Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology IRVINE, Calif., Nov 01, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Masimo, the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, announced the completion of CHN's system-wide implementation of Masimo SET pulse oximetry.
10/30/07

Summary Toggle Masimo Reports Third Quarter 2007 Financial Results Record results mark 17th consecutive quarter of revenue growth Third Quarter Highlights: * Product revenues increased 29% to a record $51.1 million * Masimo SET pulse oximeter units increase 32% to a record 30,800 units IRVINE, Calif., Oct.
10/25/07

Summary Toggle Breaking Studies - Masimo's Technologies the Focus of Multiple Clinical Studies at Last Week's American Society of Anesthesiologists' Annual Meeting New studies show Masimo provides unique benefits in pulse oximetry, as well as noninvasive blood constituent and functional hemodynamic monitoring IRVINE, Calif., Oct 25, 2007 /PRNewswire via COMTEX News Network/ -- New studies show Masimo provides unique benefits in pulse oximetry, as well as nonin
10/18/07

Summary Toggle Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007 Conference call and webcast with Masimo CEO and CFO to begin after markets close at 2:00 pm PT (5:00 pm ET) IRVINE, Calif., Oct.
10/15/07

Summary Toggle Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume Most recent addition to Masimo Rainbow SET platform seen as having potential clinical application for the noninvasive detection of hypovolemia and fluid responsiveness monitoring SAN FRANCISCO, Oct.
10/04/07

Summary Toggle Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting The New Masimo Patient SafetyNet and the Innovative, Upgradable Masimo Rainbow SET Technology Platform Will Help Clinicians Meet Standards Bodies' Calls to Improve Patient Safety IRVINE, Calif., Oct.
09/19/07

Summary Toggle Masimo Reports Second Quarter 2007 Financial Results Record results mark 16th consecutive quarter of revenue growth Second Quarter Highlights: Product revenues increase 26% to a record $47.6 million A record 29,600 Masimo SET pulse oximeter units shipped Net income of $10.6 million.$0.13 GAAP EPS / $0.19 Non-GAAP EPS IRVINE, Calif., Sept.
09/12/07

Summary Toggle Masimo to Report Second Quarter 2007 Financial Results on September 19, 2007 IRVINE, Calif., Sept.

Receive E-mail Alerts

To request a copy of the Annual Report, click here .